Stocks and Investing
Stocks and Investing
Thu, April 11, 2024
[ Thu, Apr 11th 2024
] - WOPRAI
[ Thu, Apr 11th 2024
] - WOPRAI
[ Thu, Apr 11th 2024
] - WOPRAI
[ Thu, Apr 11th 2024
] - WOPRAI
[ Thu, Apr 11th 2024
] - WOPRAI
[ Thu, Apr 11th 2024
] - WOPRAI
[ Thu, Apr 11th 2024
] - WOPRAI
[ Thu, Apr 11th 2024
] - WOPRAI
[ Thu, Apr 11th 2024
] - WOPRAI
[ Thu, Apr 11th 2024
] - WOPRAI
[ Thu, Apr 11th 2024
] - WOPRAI
[ Thu, Apr 11th 2024
] - WOPRAI
[ Thu, Apr 11th 2024
] - WOPRAI
[ Thu, Apr 11th 2024
] - WOPRAI
[ Thu, Apr 11th 2024
] - WOPRAI
[ Thu, Apr 11th 2024
] - WOPRAI
[ Thu, Apr 11th 2024
] - WOPRAI
[ Thu, Apr 11th 2024
] - WOPRAI
[ Thu, Apr 11th 2024
] - WOPRAI
[ Thu, Apr 11th 2024
] - WOPRAI
[ Thu, Apr 11th 2024
] - WOPRAI
[ Thu, Apr 11th 2024
] - WOPRAI
[ Thu, Apr 11th 2024
] - WOPRAI
[ Thu, Apr 11th 2024
] - WOPRAI
[ Thu, Apr 11th 2024
] - WOPRAI
[ Thu, Apr 11th 2024
] - WOPRAI
[ Thu, Apr 11th 2024
] - WOPRAI
[ Thu, Apr 11th 2024
] - WOPRAI
Liisa Bayko Upgraded (VRTX) to Buy and Held Target at $438 on, Apr 11th, 2024
Liisa Bayko of Evercore ISI Group, Upgraded "Vertex Pharmaceuticals Incorporated" (VRTX) to Buy and Held Target at $438 on, Apr 11th, 2024.
Liisa has made no other calls on VRTX in the last 4 months.
There are 11 other peers that have a rating on VRTX. Out of the 11 peers that are also analyzing VRTX, 3 agree with Liisa's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Brian Abrahams of "RBC Capital" Maintained at Hold with Increased Target to $420 on, Tuesday, February 6th, 2024
- William Pickering of "Bernstein" Downgraded from Buy to Hold on, Friday, February 2nd, 2024
- Naz Rahman of "Maxim Group" Downgraded from Strong Buy to Hold on, Wednesday, January 31st, 2024
These are the ratings of the 8 analyists that currently disagree with Liisa
- Olivia Brayer of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $440 on, Tuesday, February 20th, 2024
- Andy Chen of "Wolfe Research" Initiated at Buy on, Thursday, February 15th, 2024
- Gena Wang of "Barclays" Maintained at Buy with Increased Target to $472 on, Tuesday, February 6th, 2024
- Jessica Fye of "JP Morgan" Maintained at Buy with Increased Target to $450 on, Tuesday, February 6th, 2024
- Mohit Bansal of "Wells Fargo" Maintained at Buy with Increased Target to $540 on, Tuesday, February 6th, 2024
- Robyn Karnauskas of "Truist Securities" Maintained at Strong Buy with Increased Target to $508 on, Wednesday, January 31st, 2024
- Salveen Richter of "Goldman Sachs" Maintained at Strong Buy with Increased Target to $559 on, Wednesday, January 31st, 2024
- Whitney Ijem of "Canaccord Genuity" Downgraded from Hold to Strong Sell and Increased Target to $379 on, Wednesday, January 24th, 2024
Contributing Sources